Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept
2025 · Molecular Metabolism · 8 citations
https://doi.org/10.1016/j.molmet.2025.102271
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
612
Citations
9
h-index
9
i10-index
Minxia M. He is an academic researcher from Eli Lilly (United States). The author has contributed to research in topics: Pharmacogenetics and Drug Metabolism & Computational Drug Discovery Methods & Drug Transport and Resistance Mechanisms. The author has an h-index of 9, co-authored 17 publications.
https://doi.org/10.1016/j.molmet.2025.102271
https://doi.org/10.1097/md.0000000000041449
Click to start Chat